Discrimination against drug addicts

Discrimination against people with substance use disorders is a form of discrimination against people
with this disease. In the United States, people with substance use disorders are often blamed for their
disease, which is often seen as a moral failing, due to a lack of public understanding about substance use
disorders being diseases of the brain with 40-60% heritability. People with substance use disorders are
likely to be stigmatized, whether in society or healthcare.

In the process of stigmatization, people with substance use disorders are stereotyped as having a
particular set of undesirable traits, in turn causing other individuals to act in a fearful or prejudicial
manner toward them.[1][2][3]

Background
Drug use discrimination is the unequal treatment people
experience because of the drugs they use.[4] People who use or
have used illicit drugs may face discrimination in employment,
welfare, housing, child custody, and travel,[5][6][7][8] in addition to
imprisonment, asset forfeiture, and in some cases forced labor,
torture, and execution.[9][10] Though often prejudicially
stereotyped as deviants and misfits, most drug users are well-
adjusted and productive members of society.[11][12] Drug
prohibitions may have been partly motivated by racism and other
prejudice against minorities,[13][14][15] and racial disparities have
been found to exist in the enforcement and prosecution of drug
laws.[16][17][18] Discrimination due to illicit drug use was the most
commonly reported type of discrimination among Blacks and
Latinos in a 2003 study of minority drug users in New York City,
double to triple that due to race.[19] People who use legal drugs Global Marijuana March, Paris.
such as tobacco and prescription medications may also face
discrimination.[20][21][22]

Individual factors
Clinicians use DSM-V-TR criteria to establish whether a person has a Substance Use Disorder, which
may be classified as mild, moderate, or severe. It may also be ruled out, as some people may use
substances or may be prescribed controlled substances that have the potential for addiction, but never go
on to develop a substance use disorder. Addictive substances include stimulants, (caffeine, cocaine,
amphetamine, methamphetamine, ephedra, etc.), sedatives/anxiolytics (benzodiazepines, barbiturates,
quaaludes, etc.), opioids (oxycodone, fentanyl, etc.), alcohol, nicotine/tobacco, cannabis, dissociatives
(ketamine, nitrous oxide, etc.), certain hallucinogens (especially MDMA), hormones (testosterone), GHB,
Kratom, gabenergic agents (such as gabapentin), and more. The term addiction usually correlates with a
severe substance use disorder. Addiction is characterized by behavior that is originally voluntary and
reward-seeking that over time, becomes compulsive, with a desire to avoid dysphoria or withdrawal
rather than to experience the original positive effects associated. A person may become physiologically
dependent, experience withdrawal, and experience significant cravings. It does not degrade their
personality, but people may engage in illicit behaviors such as buying drugs that are controlled
substances, or engaging in prostitution to fund their addiction. Since these behaviors are illegal and they
may face legal issues as a result, people who use drugs may not be forthcoming about these practices and
may also delay seeking medical treatment for sequelae related to substance use out of fear of stigma or
legal consequences.

Institutional basis
Stigma by health care professionals has many contributing factors. The first is a well-documented,
decades-long lack of education on substance use disorders in many healthcare professions, such as
medicine, nursing, and pharmacy. Due to this gap in educational curricula, and competency, healthcare
professionals may be unaware of how much of what they assume to be true about treatment and people
with substance use disorders is neither evidence-based nor factual. Very few providers are certified in
addiction treatment; addiction is often thought of as a subspecialty with providers having an initial
certification in another specialty area, such as psychiatry. Healthcare professionals may hold biases
similar to those of the general US population, who often see substance use disorders as a moral failure
rather than a chronic brain disease that has significant contributory racial and psychosocial factors, with
40-60% heritability. Unfortunately, healthcare providers may perpetuate stigma when they use language
that is stigmatizing/non-factual or refuse to provide care that is evidence-based or person-centered as a
result of their lack of competency or biases which may be subconscious. Unfortunately, they may also
believe stereotypes about people with substance use disorders or drugs, that the general population holds.
These include people with SUDs not being able to get better when they have similar relapse rates to
people with diabetes or hypertension, and most people with SUDs recovering without treatment. What is
more, medications for opioid use disorder are highly effective at preventing relapse; methadone and
buprenorphine specifically also prevent all-cause mortality by more than 70% in patients with OUD.
However, medical providers may hold the false belief that in being prescribed these, patients are
"substituting one drug for another". Medications for Opioid Use Disorder (MOUD), Medications for
Alcohol Use Disorder (MAUD), and medications for Tobacco Use Disorder, are widely used in the
United States Healthcare System. However, regulatory and legal barriers to methadone and
buprenorphine prescription have inhibited their utility. Under current law, people on methadone have to
go to SAMHSA-approved OTPs (special facilities) to receive this medication, on a nearly daily basis.
Although now removed, until recently providers who wanted to prescribe buprenorphine had to be x-
waivered, receiving addition education to prescribe, and were limited in the number of patients they could
prescribe for. SAMHSA and ASAM have clinical guidelines for things such as medications for addiction
treatment, withdrawal management, and non-pharmacological therapeutic interventions as well.

There are several terms related to addiction that are not stages of addiction per se. Tolerance means the
need to take more of a substance to achieve the desired effect when compared to before--it does not
matter what the desired effect is (pain control/focus/euphoria/etc.). Tolerance to opioids can develop
rapidly. Tolerance may occur in addiction but also occurs in those who are prescribed certain medications
who may not meet DSM-V-TR criteria for a Substance Use Disorder. Tolerance quickly develops to the
effects of hallucinogens after a few administrations, which is part of the reason why addiction to this class
of substances is rare. When people describe dependence in addiction treatment, they often mean
physiological rather than psychological dependence. If someone is physiologically dependent, they are
likely to experience withdrawal once the substance is removed, as their body has become accustomed to
the substance's presence and its presence has affected their body's homeostasis. Withdrawal symptoms are
often unpleasant and are typically the opposite of those experienced during intoxication. Rarely,
withdrawal can be life-threatening; this may occur in patients with benzodiazepine, alcohol, or barbiturate
dependence for example. Withdrawal is not a stage of addiction but is often a symptom, although a few
drugs do not have withdrawal as part of their DSM-V-TR criteria (hallucinogens and cannabis).

People with substance use disorders may have co-occurring mental health disorders, substance-induced
mental disorders, both, or not have mental health disorders. Substance-use disorders are not thought of as
mental health disorders, but can induce acute symptoms such as mood alterations or psychosis, depending
on the drug and whether a person is intoxicated, experiencing withdrawal. In some cases, a person can be
in active recovery (methamphetamine-induced psychosis specifically can last up to 2 years following
discontinuation of methamphetamine, and hallucinogen persistent perception disorder can last several
months following discontinuation). Generally, however, substance induced mental health symptoms are
time-limited, clearing up within one month or less based on DSM-V-TR criteria. If symptoms persist for
longer following discontinuation, providers may consider a mental health disorder as primary, or as
stemming from a different etiology, rather than as substance-induced. Thus the person's diagnosis may
change based on the timeframe and symptoms following discontinuation. People with substance use
disorders still have agency, but it may be very difficult to control cravings and urges in early recovery.
Therefore, people who use drugs win early recovery may avoid people, places, or things, that serve as
triggers for these. If unavoidable, they may urge surf, call a friend or sponsor, or use other coping
mechanisms to distract themselves or ride the cravings and urges out. While much substance use is
initially voluntary, this is not always the case. People may be exposed to substances in utero, or
involuntarily initially in childhood (especially if parents use or manufacture drugs) or in adulthood (e.g.
GHB, rophynol, etc.). Some people who use may use substances that do not know are contaminated
(laced) with other substances, such as fentanyl, nitrazine, or xylazine. This is a significant problem, with
the DEA reporting fentanyl-related overdoses are the #1 cause of death in people 18-45.

Although 1 in 10 people in the United States will meet criteria for a substance use disorder in their
lifetime, few will receive treatment.

With the increasing number of adults that suffer from an addiction, only a few will receive treatment due
to the complexity of health care systems.[23] Most health care systems do not have insurance coverage for
addiction recovery and many health care providers have little to no training in treating addiction.[24]
Some doctors do not feel comfortable treating addictions, due to their lack of knowledge and training of
the topic.[25] The American Society of Addiction Medicine reports that there are only 3,000 board-
certified addiction specialist physicians in the United States while there are nearly 2 million people
experiencing opioid addiction.[26] The limited presence and access to comprehensive care for addiction
poses a barrier for recovery for many, particularly those hailing from lower socioeconomic
backgrounds.[27]

Role of language
Stigma founded in societal preconceptions about substance dependence often perpetuates discrimination
against those with Substance use disorder (SUD).[28] How language regarding SUD is framed plays an
important role in mediating stigma experienced by those with the condition, which can consequently
shape critical outcomes for this population such as treatment contact, social isolation, and attitudes
towards healthcare providers.[28] Shifting towards person-first language has been emphasized in
healthcare provider circles to mitigate such stigma. For instance, as opposed to saying "former addict" or
"reformed addict", the National Institute on Drug Abuse (NIDA) recommends language such as "person
in recovery" or "person who previously used drugs" to separate the problem from the
individual.[29][30][31] The NIDA additionally applies a similar framework to terminology such as "clean"
or "dirty" to denote whether or not someone is actively using as they cite the former vocabulary holds
punitive connotations.[31][32] Moreover, SUD policy reform advocates report language adjacent to SUD
can misconstrue associated medical treatment practices which in turn poses barriers to expanded harm
reduction efforts from being adopted.[32] An example of this provided in a 2017 executive memorandum
from The National Prevention Council was a recommendation to wean usage of "opioid substitution
replacement therapy" which many believe falsely alludes that an individual is substituting their addiction
for another (i.e. from heroin to methadone) to "opioid agonist therapy".[29][32] Another term that is losing
favor is "abuse", due to its negative connotations and its impact on patient care. Instead, the terms
"misuse" for prescribed medications or "use" for illicit substances are used. Similarly, "user" is not used
in favor of person-first language, such as "person with a substance use disorder", or "person who uses
intraveneously"

Drugs and HIV infection

Among people who use drugs intravenously, the incidence of HIV and Hepatitis C infection is higher than
among those who administer drugs through other routes. However punitive and discriminatory measures
against people who use drugs are not able to eliminate either the spread of drug addiction or HIV.
Researchers say that around 90% of people who choose to inject drugs have missed prior opportunities
for HIV testing that were provided.[33] This is why annual screening for Hep C and HIV is recommended
for patients who use drugs. Also, in states where it is legal, people may use syringe service programs, or
use at safe consumption sites. Also, patients may employ other harm reduction measures, such as
employing aseptic technique, to reduce their risk of exposure to infectious disease. The website
NextDistro has harm reduction resources for people who use drugs to minimize the risk associated with
intravenous use.

Regional patterns

Africa
In Africa, approximately 28 million people use substances.[34] This number is impacted by the rising
availability of drugs that can be administered intraveneously such as heroin, cocaine, and
methamphetamine.[34] Socio-demographic factors are often primary determinants of the health status of
people who use drugs.[34] These factors contribute to an individual's drug use behaviors such as the
sharing of needles and the solicitation of sex in exchange for police protection or more drugs.[34]
Nutritional status, family support, stigma/discrimination, adherence to medication, and recovery from
addiction are also impacted by these socio-demographic factors.[34] Research shows that the majority of
people who use drugs transition from the use of non-soluble substances s to substances that can be used
intravenously or end up using both simultaneously.[34]

Kenya
In Kenya there is a link between injection-related discrimination, mental health, physical health, and the
quality of life for those who inject drugs.[35] The rates of discrimination are linked to higher levels of
psychological distress and risky behaviors.[35] Women in Kenya account for 10% of people who use
drugs.[35] These women tend to experience typical discrimination faced by people who use drugs in
addition to gender-related discrimination.[35] Levels of discrimination are often higher for those that are
also HIV positive.[35]

Tanzania
The Tanzanian government initiated support for substance-dependence treatment rehabilitation in the
latter 20th century, with the Ministry of Health administering the Treatment II center network to oversee
this care.[36] Treatment centers and harm reduction efforts in Tanzania have come into conflict with recent
discourse from politicians, such as President John Magufuli, who established the nation's war on drugs in
early 2017.[37] Calling for the arrest of anyone involved in narcotics, Magufuli's stance is distinct from
growing harm reduction pathways established in sub-Saharan Africa in the early decades of 2000.[37]
This wave of criminalization policy aims to redress the issue of those who use being primarily being
targeted by law enforcement, rather than other individuals involved in the trafficking schema.[38]
Tanzania's policing of injection drug use has encouraged both consumers and traffickers to further
ingratiate themselves in the nation's black market, with injection drug users consequently being more
likely to be involved in sex work and other illicit trafficking, rather than engage in traditional
employment opportunities which risk greater exposure.[39] Populations that exist at this intersection, for
instance, Tanzanian women sex workers who engage in injection drug use, are alienated from utilizing
risk reduction interventions due to fear of arrest.[40]

Low-income, urban, young men which are the most likely populace to be recruited to illicit substance
trafficking due to lack of economic opportunity otherwise, have been highly scrutinized under recent
waves of drug criminalization.[41] Substance use ranging from marijuana to heroin is prohibited and a
record denoting arrest for such use highly influences subsequent employment outcomes after time served
for these individuals, which can ultimately be deleterious to expanding economic mobility within the
communities they hail from.[42]

A study published in the Review of African Political Economy notes that commerce and political
corruption in Tanzania have promulgated crack cocaine consumption and flash-blood practices, or blood
sharing between substance users after recent injections, specifically among poor youth in urban
centers.[43]

Asia

India
Narcotic substance consumption is prohibited in India by the Narcotic Drugs and Psychotropic
Substances Bill inducted in 1985, which also levies punitive measures on adjacent activities such as
production or vending of such substances.[44] Possession of a controlled substance can result in
punishment ranging from a $136.21 USD fine and half a year imprisonment to $121,261 USD and twenty
years imprisonment, depending on whether the amount identified is considered small or commercial.
Certain crimes outlined by the Narcotic Drugs and Psychotropic Substances Bill are also eligible for the
death penalty, and while cases involving marijuana have been charged with capital punishment in the
past, they tend to be successfully appealed in higher courts.[45] This legislation is heavily influenced by a
coordinated United Nations effort throughout the latter twentieth century to stymie international drug
trafficking.[46]

According to the International Drug Policy Consortium, India's Narcotics Control Bureau, which
executes the various facets of the Narcotic Drugs and Psychotropic Substances Bill, has encountered
criticism for the legislation's stringent measures which have limited access to pain-relief medication,
specifically the prescription of opiates for post-operative patients.[47] Bill revisions in response have
expanded access to such substances, like methadone, to be distributed through recognized care providers,
and members of parliaments have subsequently pushed for expanded bill protections for marijuana use,
which has not gained traction.[48] Language cited as demeaning within the 2012 National Policy on Drugs
and Psychotropic Substances regarding harm reduction pipelines such as clean needle programs, referring
to such as "shooting galleries," have posed barriers to preventing comorbidities such as HIV which are
prevalent among people who inject drugs in India.[49] This poses an issue in states such as Punjab where
over 20% of people who inject drugs are also infected with HIV.[50]

Philippines
In the Philippines, the government's war on drugs has led to allegations of killings and other human rights
violations by the Philippine National Police against drug suspects.[51]

This has led the United Nations Human Rights Council to adopt a resolution urging the Philippine
government to set up an investigation into mass killings during the war on drugs.[52]

Vietnam
Drug control strategy in modern Vietnam was first formally introduced in 1990 around the cause of
eradicating "social evils," in reference to substance use.[53] Such policies were inspired by the UN, and
specifically, its International Drug Conventions which took placed from the latter 1960s to 1997.[54]
Ordinances and violation measures were propositioned by the Vietnamese National Assembly in this
legislation to mandate compulsory treatment for substance users, rather than subject them to prison.[55]
High input in mandatory treatment centers has resulted in a tendency for there to be more patients at
treatment centers than can be handled, thus limiting access to rehabilitation for these individuals.[56]
Harm reduction measures such as clean needles and condom access have been introduced throughout the
2000s at a national level to address the prevalence of HIV and HCV among drug users.[56]
Inconsistencies between the Ordinance on HIVAIDS which outlines such harm reduction practices, and
the Drug Law of 2000, which prohibits the distribution of materials like needles, has made provincial
adoption of harm reduction institutions, like syringe exchanges, challenging.[57]
While Vietnamese policy leaders generally veer towards addressing substance use as a medical issue,
rather than criminal activity, having decriminalized many substances since 2009, the Ordinance of
Administrative Violation continues to classify illicit substance consumption as a crime.[55] Consequently,
at a local level, substance users remain eligible to be charged by law enforcement and subjected to forced
labor treatment centers that are comparable to detention.[58] Thus, many substance users do not access
harm reduction institutions out of fear of being identified by law enforcement and placed in these
conditions.[58]

Europe

Sweden
Narcotic substance use is criminalized in Sweden, with drug offenses holding punishments ranging from
fines to six months imprisonment.[59] To apprehend people who use, law enforcement is permitted to
conduct urine testing based on suspicion, rather than wholly requiring a public disturbance.[60] Such
protocol is justified by lawmakers as a way to expand early intervention for people who use substances to
be referred to rehabilitation channels, but legal advocates have challenged such practices for infringing
upon personal freedoms.[60][61] Diversion to court-ordered treatment programs rather than criminalization
has been expanded in response during the early 21st century. However, there are disparities in
representation in such programs.[61] For example, people who use drugs found in violation who belong to
the top third Swedish wealth bracket are twice as likely to be admitted into a treatment program rather
than imprisoned compared to people who committed a similar offense but belong to the bottom two-
thirds of the wealth bracket.[61] Moreover, while those who use drugs can apply to their local welfare
administrator for rehabilitative services, this process is selective despite being less costly than long-term
imprisonment for an associated drug-related crime.[62]

Sweden has faced criticism for having harsher drug policies and less accessible rehabilitative programs
for people who use drugs than peer Nordic nations which are moving towards drug liberalization.[61]
Many cite this for why Sweden has rising substance-related mortality in the 21st century, for instance,
having 157 overdose deaths in 2006 compared to the Netherlands which had a little over a hundred
despite having a population close to double the size.[63] Zero-tolerance policies are also in place for those
who drive under the influence of an illicit substance.[64]

North America

Canada
In Vancouver, Canada, there have been efforts to reduce opioid-related deaths. An article published by the
Canadian Medical Association Journal discusses new efforts to create safe injection sites for people
struggling with opioid addiction. Vancouver politicians created these sites for people to safely use drugs
that they are addicted to without the risk of infection or prosecution by the police. These safe injection
sites provide sterilized needles to limit the reuse of needles that lead to the spread of AIDS and other
diseases.[65] Drug addicts in Vancouver have been discriminated against on numerous occasions. Mothers
who are said to be drug addicts have had their children taken away, as they are thought to be unfit
mothers. These women have a hard time getting jobs because employers might not want to hire someone
who they believe are drug addicts. Women have started a union for drug users in Vancouver to aid them
with housing and education to help them get back on their feet.

United States
The War on Drugs, which formalized in the 1970s with the Nixon
administration, has disparately affected communities of color in
the United States.[67] Substantial punitive measures exist for illicit
possession, whether that be in the context of use, trafficking, or
selling, with length of incarceration scaling up with repeat
offenses.[68][69] Charges can go up to life without parole for third-
time offenses related to opioids such as fentanyl.[69] Three-
quarters of those imprisoned for fentanyl today are people of The Prison Policy Initiative cites that
the criminalization of drug use in the
color, which directly corresponds to Black and Latin populations
United States can limit personal
being disproportionately policed for drug-related crimes.[70] This
daily activities for those who may
additionally infringes upon voting eligibility among people who use substances, even if it is done in
use drugs, as more extreme drug charges hold felony status which a safe, recreational manner.[66]
revokes voting rights in a majority of states. [71] Drug
criminalization moreover operates within the deportation pipeline
in the US, with drug charges making all individuals without citizenship eligible for deportation.[72] This
includes marijuana-related charges which have constituted over ten thousand deportations from 2012 to
2013, often severing families and communities.[72] While statewide measures to legalize marijuana have
gained traction throughout 2010, individuals of color have been less likely to receive post-carceral
clemency for these charges due to barriers to legal advocacy.[73]

Human rights advocates have criticized the use of demeaning language regarding the condition in
criminal litigation to leverage character assault against defendants or victims who have or are presumed
to have the condition.[74] A prominent example of this is the trial of Derek Chauvin, the former
Minneapolis police officer convicted of murdering George Floyd, whose legal defense asserted substance
use as a potential cause of death, rather than the asphyxiation which incurred from Chauvin.[75]

In the US, employers and educational institutions may legally discriminate against people who are
currently using based on the results of their drug screens. Otherwise, the ADA protects people with a
prior history of substance use or who are receiving treatment. Employers may elect to administer drug
screens at random, upon suspicion, on a routine basis, and before employment as a prerequisite as part of
a zero-tolerance policy.[76] However, according to the Rehabilitation Act of 1973, employers are
supposed to ensure that people with alcohol use disorder and substance use disorders receive needed
treatment and accommodations. The lack of job opportunities and treatment for people with substance use
disorders may result in relapses or jail time .[77] Nathan Kim and his associates once conducted a study
on the HIV status of people who inject drugs and found that the HIV rate in those individuals in San
Francisco increased by 16.1% from the year 2009 when the HIV rate was 64.4%, to 80.5% in 2015.[78]

See also
Cognitive liberty
 Drug liberalization
Legalisation of marijuana

References
1. Corrigan P, Schomerus G, Shuman V, Kraus D, Perlick D, Harnish A, Kulesza M, Kane-
Willis K, Qin S, Smelson D (January 2017). "Developing a research agenda for
understanding the stigma of addictions Part I: Lessons from the Mental Health Stigma
Literature". The American Journal on Addictions. 26 (1): 59–66. doi:10.1111/ajad.12458 (htt
ps://doi.org/10.1111%2Fajad.12458). PMID 27779803 (https://pubmed.ncbi.nlm.nih.gov/277
79803). "Social psychologists have distinguished the largely private experience of stigma in
general—stereotypes and prejudice—from the more public, behavioral result which is
discrimination.[11] Stereotypes are harmful and disrespectful beliefs about a group. Table 1
lists several examples of stereotypes applied to people with addictions including blame,
dangerousness, and unpredictability."
2. Corrigan PW, Schomerus G, Shuman V, Kraus D, Perlick D, Harnish A, Kulesza M, Kane-
Willis K, Qin S, Smelson D (January 2017). "Developing a research agenda for reducing the
stigma of addictions, part II: Lessons from the mental health stigma literature". The
American Journal on Addictions. 26 (1): 67–74. doi:10.1111/ajad.12436 (https://doi.org/10.1
111%2Fajad.12436). PMID 27875626 (https://pubmed.ncbi.nlm.nih.gov/27875626).
3. McLaughlin D, Long A (October 1996). "An extended literature review of health
professionals' perceptions of illicit drugs and their clients who use them". Journal of
Psychiatric and Mental Health Nursing. 3 (5): 283–8. doi:10.1111/j.1365-
2850.1996.tb00127.x (https://doi.org/10.1111%2Fj.1365-2850.1996.tb00127.x).
PMID 9004621 (https://pubmed.ncbi.nlm.nih.gov/9004621).
4. Ahern J, Stuber J, Galea S (May 2007). "Stigma, discrimination and the health of illicit drug
users". Drug and Alcohol Dependence. 88 (2–3): 188–96.
doi:10.1016/j.drugalcdep.2006.10.014 (https://doi.org/10.1016%2Fj.drugalcdep.2006.10.01
4). PMID 17118578 (https://pubmed.ncbi.nlm.nih.gov/17118578). "In addition to the burdens
of stigmatization, those who use illicit drugs experience discrimination." "We define drug use
discrimination as experiences of rejection and unequal treatment attributed to drug use."
5. Della Costa C (2015-06-15). "How Employee Drug Testing Targets the Poor and Minorities"
(http://www.cheatsheet.com/business/how-employee-drug-testing-targets-the-poor-and-min
orities.html/?a=viewall). The Cheat Sheet. Retrieved 2015-07-02."Roughly 40% of U.S.
employees are subjected to drug testing during the hiring process. The rate of employee
drug testing has increased 277% since 1987, and drug testing has even expanded to
welfare programs in some states."
6. Greenhouse L (2002-03-27). "Justices Rule Drug-Eviction Law Is Fair" (https://www.nytimes.
com/2002/03/27/us/justices-rule-drug-eviction-law-is-fair.html). New York Times. Retrieved
2015-07-02.
7. Wyatt K (2014-06-15). "Changing pot laws create gray areas in child-welfare and custody
cases" (https://www.washingtonpost.com/national/changing-pot-laws-create-gray-areas-in-c
hild-welfare-and-custody-cases/2014/06/15/594e752c-f49b-11e3-b633-0de077c9f768_story.
html). The Washington Post. Retrieved 2015-07-01.
8. "Nigella Lawson stopped from boarding flight to US after cocaine confession" (https://www.t
heguardian.com/lifeandstyle/2014/apr/03/nigella-lawson-stopped-boarding-flight-us-cocaine-
confession). The Guardian. 2014-04-03. Retrieved 2015-07-05. "The US department of
homeland security told the Mail that foreigners who had admitted drug taking were deemed
"inadmissible"."
9. Szalavitz M (2012-08-06). "Human Rights Watch: Hundreds of Thousands Still Tortured in
Name of Drug Treatment" (https://healthland.time.com/2012/08/03/human-rights-watch-hund
reds-of-thousands-still-tortured-in-name-of-drug-treatment/). Time. Retrieved 2015-07-01.
10. Dehghan SK (2012-06-25). "Iranian pair face death penalty after third alcohol offence" (http
s://www.theguardian.com/world/2012/jun/25/iranian-pair-death-penalty-alcohol). The
Guardian. Retrieved 2015-07-01."Under Iranian Sharia law, certain crimes such as sodomy,
rape, theft, fornication, apostasy and consumption of alcohol for the third time are
considered to be "claims of God" and therefore have mandatory death sentences."
11. Bennetto J, Todd B (1997-11-05). "Habits: Most drug users are happy, successful people
with a taste for the good life" (https://www.independent.co.uk/news/habits-most-drug-users-a
re-happy-successful-people-with-a-taste-for-the-good-life-1292155.html). The Independent.
Retrieved 2015-07-02."According to a survey of more than 850 people aged between 16
and 24, and 100 in-depth interviews, drug use is commonplace and consumers tend to be
independent, lead active lives, and do not lack self-esteem."
12. Nicholson T, White J, Duncan D (September 1998). "Drugnet: A Pilot Study of Adult
Recreational Drug Use via the WWW". Substance Abuse. 19 (3): 109–121.
doi:10.1080/08897079809511380 (https://doi.org/10.1080%2F08897079809511380).
PMID 12511811 (https://pubmed.ncbi.nlm.nih.gov/12511811). S2CID 32125794 (https://api.
semanticscholar.org/CorpusID:32125794). "This survey further documents the existence of
a nonclinical population of drug users which is generally healthy, well-adjusted, and
productive."
13. Block F (2013-01-03). "Racism's Hidden History in the War on Drugs" (http://www.huffington
post.com/judge-frederic-block/war-on-drugs_b_2384624.html). Huffington Post. Retrieved
2015-07-05. "A 1914 New York Times article proclaimed: "Negro Cocaine 'Fiends' Are a New
Southern Menace: Murder and Insanity Increasing Among Lower Class Blacks Because
They Have Taken to 'Sniffing.'" A Literary Digest article from the same year claimed that
"most of the attacks upon women in the South are the direct result of the cocaine-crazed
Negro brain." It comes as no surprise that 1914 was also the year Congress passed the
Harrison Tax Act, effectively outlawing opium and cocaine."
14. Staples B (2014-07-29). "The Federal Marijuana Ban Is Rooted in Myth and Xenophobia" (ht
tps://www.nytimes.com/2014/07/30/opinion/high-time-federal-marijuana-ban-is-rooted-in-myt
h.html). The New York Times. Retrieved 2015-07-05. "As the legal scholars Richard Bonnie
and Charles Whitebread explain in their authoritative history, "The Marihuana Conviction,"
the drug's popularity among minorities and other groups practically ensured that it would be
classified as a "narcotic," attributed with addictive qualities it did not have, and set alongside
far more dangerous drugs like heroin and morphine."
15. Sandy KR (2003). "The Discrimination Inherent in America's Drug War: Hidden Racism
Revealed by Examining the Hysteria over Crack" (http://www.law.ua.edu/pubs/lrarticles/Volu
me%2054/Issue%202/Sandy.pdf) (PDF). Alabama Law Review. 54 (2): 665–693. Retrieved
2015-07-05. "Myths about the "superhuman strength, cunning and efficiency" of the Negro
on cocaine flourished in the South. Such myths included ideas such as cocaine induced
Black men to rape White women, cocaine improved Black marksmanship, and cocaine
made Blacks impervious to .32 caliber bullets ("caus[ing] southern police departments to
switch to .38 caliber revolvers")."
16. McKinley J (2014-07-08). "Study Finds Racial Disparity in Criminal Prosecutions" (https://ww
w.nytimes.com/2014/07/09/nyregion/09race.html). The New York Times. Retrieved
2015-07-06. "One of the starkest disparities emerged in the prosecution of misdemeanor
drug crimes like possession of marijuana or cocaine. The study found blacks were 27
percent more likely than whites to receive jail or prison time for misdemeanor drug offenses,
while Hispanic defendants were 18 percent more likely to be incarcerated for those crimes."
17. Kurtzleben D (2010-08-03). "Data Show Racial Disparity in Crack Sentencing" (https://web.a
rchive.org/web/20150706230958/http://www.usnews.com/news/articles/2010/08/03/data-sho
w-racial-disparity-in-crack-sentencing). U.S. News and World Report. Archived from the
original (https://www.usnews.com/news/articles/2010/08/03/data-show-racial-disparity-in-cra
ck-sentencing) on 2015-07-06. Retrieved 2015-07-06. "According to U.S. Sentencing
Commission figures, no class of drug is as racially skewed as crack in terms of numbers of
offenses. According to the commission, 79 percent of 5,669 sentenced crack offenders in
2009 were black, versus 10 percent who were white and 10 percent who were Hispanic."
18. Berman D, Protass H (2013-07-29). "Obama Can Fix the Race Gap in Sentencing Law" (htt
p://www.slate.com/articles/news_and_politics/jurisprudence/2013/07/obama_needs_to_fix_t
he_crack_cocaine_sentencing_gap.html). Slate. Retrieved 2015-07-06. "...from 1988 to
1995 not a single white person was charged with crack-related crimes in 17 states, including
major cities such as Boston, Denver, Chicago, Miami, Dallas, and Los Angeles."
19. Minior T, Galea S, Stuber J, Ahern J, Ompad D (Fall 2003). "Racial differences in
discrimination experiences and responses among minority substance users". Ethnicity &
Disease. 13 (4): 521–7. PMID 14632272 (https://pubmed.ncbi.nlm.nih.gov/14632272). "500
Black and 419 Latino active substance users."
20. Sulszberger AG (2011-02-11). "Hospitals Shift Smoking Bans to Smoker Ban" (https://www.
nytimes.com/2011/02/11/us/11smoking.html). The New York Times. Retrieved 2015-07-04.
"Smokers have been turned away from jobs in the past — prompting more than half the
states to pass laws rejecting bans on smokers — but the recent growth in the number of
companies adopting no-smoker rules has been driven by a surge of interest among health
care providers, according to academics, human resources experts and tobacco opponents."
"Some even prohibit nicotine patches."
21. Hargrove D (2011-01-19). "Antismoking Law: Where Do the Smoker's Rights End?" (http://w
ww.sandiegoreader.com/news/2011/jan/19/citylight-antismoking-law/). San Diego Reader.
Retrieved 2015-07-04. "According to the American Lung Association's Center for Tobacco
Policy and Organizing, 12 cities and 1 county in California have adopted ordinances that
ban smoking in some percentage of multiunit apartment buildings."
22. Katie Z, Goodnough A (2010-10-24). "Drug Testing Poses Quandary for Employers" (https://
www.nytimes.com/2010/10/25/us/25drugs.html). The New York Times. Retrieved
2015-07-04. "What companies consider an effort to maintain a safe work environment is
drawing complaints from employees who cite privacy concerns and contend that they should
not be fired for taking legal medications, sometimes for injuries sustained on the job."
23. Substance Abuse Mental Health Services Administration (US); Office of the Surgeon
General (US) (November 2016). Facing Addiction in America: The Surgeon General's
Report on Alcohol, Drugs, and Health (https://www.ncbi.nlm.nih.gov/books/NBK424857/).
Reports of the Surgeon General. US Department of Health and Human Services.
PMID 28252892 (https://pubmed.ncbi.nlm.nih.gov/28252892).
24. Biancarelli, Dea L, Katie B Biello, Ellen Childs, M Drainoni, Peter Salhaney, Alberto Edeza,
Matthew J Mimiaga, Richard Saitz, and Angela R Bazzi. "Strategies Used by People Who
Inject Drugs to Avoid Stigma in Healthcare Settings." Drug and alcohol dependence 198
(2019): 80–86.
25. Substance Abuse and Mental Health Services Administration. (2018). Key substance use
and mental health indicators in the United States: Results from the 2017 National Survey on
Drug Use and Health (HHS Publication No. SMA 18-5068, NSDUH Series H-53). Rockville,
MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental
Health Services Administration. Retrieved from https://www.samhsa.gov/data/
26. Langabeer, James R, Angela L Stotts, Bentley J Bobrow, Henry E Wang, Kimberly A
Chambers, Andrea J Yatsco, Marylou Cardenas-Turanzas, and Tiffany Champagne-
Langabeer. "Prevalence and Charges of Opioid-Related Visits to U.S. Emergency
Departments." Drug and alcohol dependence 221 (2021): 108568–108568.
27. Saloner, Brendan, and Benjamin Le Cook. "Blacks And Hispanics Are Less Likely Than
Whites To Complete Addiction Treatment, Largely Due To Socioeconomic Factors." HEALTH
AFFAIRS 32, no. 1 (2013): 135–145.
28. Kelly, John F.; Saitz, Richard; Wakeman, Sarah (2016-01-02). "Language, Substance Use
Disorders, and Policy: The Need to Reach Consensus on an "Addiction-ary" ". Alcoholism
Treatment Quarterly. 34 (1): 116–123. doi:10.1080/07347324.2016.1113103 (https://doi.org/
10.1080%2F07347324.2016.1113103). ISSN 0734-7324 (https://search.worldcat.org/issn/0
734-7324). S2CID 146767164 (https://api.semanticscholar.org/CorpusID:146767164).
29. Brener, Loren; von Hippel, William; von Hippel, Courtney; Resnick, Ilyse; Treloar, Carla
(September 2010). "Perceptions of discriminatory treatment by staff as predictors of drug
treatment completion: Utility of a mixed methods approach" (https://doi.org/10.1111%2Fj.14
65-3362.2010.00173.x). Drug and Alcohol Review. 29 (5): 491–497. doi:10.1111/j.1465-
3362.2010.00173.x (https://doi.org/10.1111%2Fj.1465-3362.2010.00173.x). ISSN 0959-
5236 (https://search.worldcat.org/issn/0959-5236). PMID 20887572 (https://pubmed.ncbi.nl
m.nih.gov/20887572).
30. Rastegar, Darius A. (August 2020), "Overview of Substance Use Disorder Treatment",
ASAM Handbook of Addiction Medicine, Oxford University Press, pp. 29–42,
doi:10.1093/med/9780197506172.003.0003 (https://doi.org/10.1093%2Fmed%2F97801975
06172.003.0003), ISBN 978-0-19-750617-2
31. "Words Matter - Terms to Use and Avoid When Talking About Addiction" (https://www.drugab
use.gov/nidamed-medical-health-professionals/health-professions-education/words-matter-t
erms-to-use-avoid-when-talking-about-addiction). National Institute on Drug Abuse. 2021-
04-08. Retrieved 2021-05-12.
32. Saitz, Richard (January 2016). "International Statement Recommending Against the Use of
Terminology That Can Stigmatize People". Journal of Addiction Medicine. 10 (1): 1–2.
doi:10.1097/adm.0000000000000178 (https://doi.org/10.1097%2Fadm.000000000000017
8). ISSN 1932-0620 (https://search.worldcat.org/issn/1932-0620). PMID 26588846 (https://p
ubmed.ncbi.nlm.nih.gov/26588846). S2CID 32717513 (https://api.semanticscholar.org/Corp
usID:32717513).
33. Stulpin, Caitlyn (20 February 2020). "90% of injection drug users miss opportunities for HIV
or HCV testing" (https://www.healio.com/news/infectious-disease/20200220/90-of-injection-d
rug-users-miss-opportunities-for-hiv-or-hcv-testing). Healio News. Infections Disease News.
34. Budambula V, Matoka C, Ouma J, Ahmed AA, Otieno MF, Were T (January 2018). "Socio-
demographic and sexual practices associated with HIV infection in Kenyan injection and
non-injection drug users" (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789578). BMC
Public Health. 18 (1): 193. doi:10.1186/s12889-018-5100-y (https://doi.org/10.1186%2Fs128
89-018-5100-y). PMC 5789578 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789578).
PMID 29378631 (https://pubmed.ncbi.nlm.nih.gov/29378631).
35. Mburu G, Ayon S, Tsai AC, Ndimbii J, Wang B, Strathdee S, Seeley J (May 2018). " 'Who
has ever loved a drug addict? It's a lie. They think a 'teja' is as bad person': multiple stigmas
faced by women who inject drugs in coastal Kenya" (https://www.ncbi.nlm.nih.gov/pmc/articl
es/PMC5970466). Harm Reduction Journal. 15 (1): 29. doi:10.1186/s12954-018-0235-9 (htt
ps://doi.org/10.1186%2Fs12954-018-0235-9). PMC 5970466 (https://www.ncbi.nlm.nih.gov/
pmc/articles/PMC5970466). PMID 29801494 (https://pubmed.ncbi.nlm.nih.gov/29801494).
36. United Nations Office on Drugs and Crime. (March 2017). Prevention of Drug Use and
Treatment of Drug Use Disorders in Rural Settings. UNODC.
37. Degenstein, Dane (2020-10-13). The War on Drugs and Social Policy in Tanzania:
Crackdowns, Prohibition and Control (http://ruor.uottawa.ca/handle/10393/41209) (Thesis
thesis). Université d'Ottawa / University of Ottawa. doi:10.20381/ruor-25433 (https://doi.org/
10.20381%2Fruor-25433).
38. Domasa, Sylivester 2018 'Tanzania: demand for drugs soars across Tanzania,' All Africa,
published online March 27, 2018. http://allafrica.com/stories/201803270668.html
39. Lambdin, Barrot H.; Lorvick, Jennifer; Mbwambo, Jessie K.; Rwegasha, John; Hassan,
Saria; Lum, Paula; Kral, Alex H. (July 2017). "Prevalence and predictors of HCV among a
cohort of opioid treatment patients in Dar es Salaam, Tanzania" (https://www.ncbi.nlm.nih.go
v/pmc/articles/PMC6166640). International Journal of Drug Policy. 45: 64–69.
doi:10.1016/j.drugpo.2017.05.043 (https://doi.org/10.1016%2Fj.drugpo.2017.05.043).
ISSN 0955-3959 (https://search.worldcat.org/issn/0955-3959). PMC 6166640 (https://www.n
cbi.nlm.nih.gov/pmc/articles/PMC6166640). PMID 28628854 (https://pubmed.ncbi.nlm.nih.g
ov/28628854).
40. Williams, Mark L.; McCurdy, Sheryl A.; Atkinson, John S.; Kilonzo, Gad P.; Leshabari, M. T.;
Ross, Michael W. (2006-09-27). "Differences in HIV Risk Behaviors by Gender in a Sample
of Tanzanian Injection Drug Users". AIDS and Behavior. 11 (1): 137–144.
doi:10.1007/s10461-006-9102-x (https://doi.org/10.1007%2Fs10461-006-9102-x).
ISSN 1090-7165 (https://search.worldcat.org/issn/1090-7165). PMID 17004117 (https://pub
med.ncbi.nlm.nih.gov/17004117). S2CID 36833665 (https://api.semanticscholar.org/CorpusI
D:36833665).
41. McCurdy, S. A.; Williams, M. L.; Kilonzo, G. P.; Ross, M. W.; Leshabari, M. T. (June 2005).
"Heroin and HIV risk in Dar es Salaam, Tanzania: Youth hangouts, mageto and injecting
practices". AIDS Care. 17 (sup1): 65–76. doi:10.1080/09540120500120930 (https://doi.org/1
0.1080%2F09540120500120930). ISSN 0954-0121 (https://search.worldcat.org/issn/0954-0
121). PMID 16096119 (https://pubmed.ncbi.nlm.nih.gov/16096119). S2CID 38646631 (http
s://api.semanticscholar.org/CorpusID:38646631).
42. McCurdy, Sheryl; Kaduri, Pamela (2016-04-02). "The political economy of heroin and crack
cocaine in Tanzania" (https://www.tandfonline.com/action/showCitFormats?doi=10.1080/030
56244.2016.1170678). Review of African Political Economy. 43 (148): 312–319.
doi:10.1080/03056244.2016.1170678 (https://doi.org/10.1080%2F03056244.2016.117067
8). ISSN 0305-6244 (https://search.worldcat.org/issn/0305-6244). S2CID 156730875 (http
s://api.semanticscholar.org/CorpusID:156730875).
43. McCurdy, Sheryl A.; Ross, Michael W.; Kilonzo, Gad Paul; Leshabari, M.T.; Williams, Mark
L. (April 2006). "HIV/AIDS and injection drug use in the neighborhoods of Dar es Salaam,
Tanzania". Drug and Alcohol Dependence. 82: S23–S27. doi:10.1016/s0376-
8716(06)80004-9 (https://doi.org/10.1016%2Fs0376-8716%2806%2980004-9). ISSN 0376-
8716 (https://search.worldcat.org/issn/0376-8716). PMID 16769441 (https://pubmed.ncbi.nl
m.nih.gov/16769441).
44. Daniel, Heilmann (June 2010), "Narcotic Drugs and Psychotropic Substances" (https://dx.do
i.org/10.1093/law:epil/9780199231690/e1069), Max Planck Encyclopedia of Public
International Law, Oxford University Press, ISBN 978-0-19-923169-0, retrieved 2021-05-11
45. "Mandatory death penalty provision may be dropped from NDPS Act" (https://timesofindia.in
diatimes.com/india/mandatory-death-penalty-provision-may-be-dropped-from-ndps-act/articl
eshow/13059105.cms). The Times of India. May 9, 2012. Retrieved 2021-05-11.
46. "Extent of drug abuse". Global Illicit Drug Trends 1999. New York: United Nations Office on
Drug Control and Crime Prevention. 1999. pp. 116–125. doi:10.18356/390ac872-en (https://
doi.org/10.18356%2F390ac872-en). ISBN 9789210041188.
47. International Narcotics Control Board (5 March 2014), INCB encourages States to consider
the abolition of the death penalty for drug-related offences, Press release,
http://www.incb.org/documents/Publications/
PressRelease/PR2014/press_release_050314.pdf
48. Seshata, The Complicated History of Cannabis in the Islamic World, Mar 25, 2016,
https://prohbtd.com/the-complicatedhistory-of-cannabis-in-the-islamic-world.
49. П.М. Мазуркин (2013). ДИНАМИКА АЛЬФА-АКТИВНОСТИ ОБРАЗЦА 239PU В
РАЗЛИЧНЫХ ШКАЛАХ ВРЕМЕНИ (https://doi.org/10.18411%2Fa-2017-023). Science and
World. 2 (2). doi:10.18411/a-2017-023 (https://doi.org/10.18411%2Fa-2017-023).
50. Dorabjee, Jimmy; Samson, Luke (March 2000). "A multi-centre rapid assessment of
injecting drug use in India". International Journal of Drug Policy. 11 (1–2): 99–112.
doi:10.1016/s0955-3959(99)00058-4 (https://doi.org/10.1016%2Fs0955-3959%2899%2900
058-4). ISSN 0955-3959 (https://search.worldcat.org/issn/0955-3959). PMID 10699547 (http
s://pubmed.ncbi.nlm.nih.gov/10699547).
51. Mogato, Manuel; Baldwin, Clare (2017-04-18). "Special Report: Police describe kill rewards,
staged crime scenes in Duterte's drug war" (https://www.reuters.com/article/us-philippines-d
uterte-police-specialrep-idUSKBN17K1F4). Reuters. Retrieved 2021-10-16.
52. "UN Human Rights Council votes to probe Philippines drug war deaths" (https://www.cbc.ca/
news/world/united-nations-investigation-philippines-drug-deaths-1.5209238). CBC. 2019-07-
11. Archived (https://web.archive.org/web/20190712032012/https://www.cbc.ca/news/world/
united-nations-investigation-philippines-drug-deaths-1.5209238) from the original on 2019-
07-12. Retrieved 2021-10-16.
53. "Vu Quang Minh". Vu Quang Minh, Director-General, Economic Affairs Department, Ministry
of Foreign Affairs, Vietnam, since 2014. Who's Who. Oxford University Press. 2013-12-01.
doi:10.1093/ww/9780199540884.013.257599 (https://doi.org/10.1093%2Fww%2F97801995
40884.013.257599).
54. 2005. Vietnam country profile. Hanoi, Vietnam: United Nations Office on Drug and Crime
(UNODC) Country Office Vietnam.
55. Vuong, Thu; Ali, Robert; Baldwin, Simon; Mills, Stephen (July 2012). "Drug policy in
Vietnam: A decade of change?". International Journal of Drug Policy. 23 (4): 319–326.
doi:10.1016/j.drugpo.2011.11.005 (https://doi.org/10.1016%2Fj.drugpo.2011.11.005).
ISSN 0955-3959 (https://search.worldcat.org/issn/0955-3959). PMID 22206713 (https://pub
med.ncbi.nlm.nih.gov/22206713).
56. Nguyen Ha, Pham; Pharris, Anastasia; Huong, Nguyen Thanh; Thi Kim Chuc, Nguyen;
Brugha, Ruairi; Thorson, Anna (2010-08-30). "The evolution of HIV policy in Vietnam: from
punitive control measures to a more rights-based approach" (https://www.ncbi.nlm.nih.gov/p
mc/articles/PMC2932461). Global Health Action. 3 (1): 4625. doi:10.3402/gha.v3i0.4625 (htt
ps://doi.org/10.3402%2Fgha.v3i0.4625). ISSN 1654-9716 (https://search.worldcat.org/issn/1
654-9716). PMC 2932461 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2932461).
PMID 20824159 (https://pubmed.ncbi.nlm.nih.gov/20824159).
57. World Bank. (2011). Evaluation of epidemiological impact of harm reduction programs on
HIV in Vietnam
58. WHO. (2009). Assessment of compulsory treatment of people who use drugs in Cambodia,
China, Malaysia and Vietnam: An application of selected human rights principles. WHO
Western Pacific Region.
59. European Monitoring Centre for Drugs and Drug Addiction (2019), Sweden, Country Drug
Report 2019, Publications Office of the European Union, Luxembourg.
60. Olsson, B., C. Adamsson-Wahren, and S. Byqvist. 2001. Det tunga narkotikamissbrukets
omfattning i Sverige 1998 (Heavy drug use in Sweden 1998). The Swedish Council for
Information on Alcohol and Other Drugs, CAN. Stockholm.
61. Lenke, Leif; Olsson, Boerje (2002-07-01). "Swedish Drug Policy in the Twenty-First Century:
A Policy Model Going Astray" (https://doi.org/10.1177%2F000271620258200105). The
Annals of the American Academy of Political and Social Science. 582 (1): 64–79.
doi:10.1177/000271620258200105 (https://doi.org/10.1177%2F000271620258200105).
ISSN 0002-7162 (https://search.worldcat.org/issn/0002-7162). S2CID 154598556 (https://ap
i.semanticscholar.org/CorpusID:154598556).
62. Gould, Arthur (October 1998). "Book Reviews: Tim Boekhout van Solinge: The Swedish
Drug Control System. Amsterdam: University of Amsterdam Centre for Drug Research,
1997". Acta Sociologica. 41 (4): 402–404. doi:10.1177/000169939804100419 (https://doi.or
g/10.1177%2F000169939804100419). ISSN 0001-6993 (https://search.worldcat.org/issn/00
01-6993). S2CID 143683007 (https://api.semanticscholar.org/CorpusID:143683007).
63. UNODC: Sweden's successful drug policy, 2007, pp. 9–12
64. "Medium- and long-term debt prospects in Eastern Europe". East-West Financial Relations:
Current Problems and Future Prospects. Cambridge University Press. 1991. pp. 77–100.
doi:10.1017/cbo9780511751868.005 (https://doi.org/10.1017%2Fcbo9780511751868.005).
ISBN 978-0-521-39530-4.
65. Jones, Deborah (24 June 2003). "Time for a new approach to heroin addiction, Vancouver
says" (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC161627). Canadian Medical
Association Journal. 168 (13): 1699. PMC 161627 (https://www.ncbi.nlm.nih.gov/pmc/article
s/PMC161627). PMID 12821633 (https://pubmed.ncbi.nlm.nih.gov/12821633).
66. "Ending automatic driver's license suspensions for drug offenses" (https://www.prisonpolicy.
org/driving/). www.prisonpolicy.org. Retrieved 2021-03-30.
67. Miron, Jeffrey; Partin, Erin (2021-04-03). "Ending the War on Drugs Is an Essential Step
Toward Racial Justice". The American Journal of Bioethics. 21 (4): 1–3.
doi:10.1080/15265161.2021.1895590 (https://doi.org/10.1080%2F15265161.2021.189559
0). ISSN 1526-5161 (https://search.worldcat.org/issn/1526-5161). PMID 33825624 (https://p
ubmed.ncbi.nlm.nih.gov/33825624). S2CID 233174284 (https://api.semanticscholar.org/Cor
pusID:233174284).
68. Tuttle, Cody (2019). "Racial Disparities in Federal Sentencing: Evidence from Drug
Mandatory Minimums". SSRN 3080463 (https://papers.ssrn.com/sol3/papers.cfm?abstract_i
d=3080463).
69. Bjerk, David (2017-01-01). "Mandatory Minimums and the Sentencing of Federal Drug
Crimes" (https://www.journals.uchicago.edu/doi/10.1086/690205). The Journal of Legal
Studies. 46 (1): 93–128. doi:10.1086/690205 (https://doi.org/10.1086%2F690205).
hdl:10419/161167 (https://hdl.handle.net/10419%2F161167). ISSN 0047-2530 (https://searc
h.worldcat.org/issn/0047-2530). S2CID 157903931 (https://api.semanticscholar.org/CorpusI
D:157903931).
70. Santoro, Taylor N; Santoro, Jonathan D (2018-12-14). "Racial Bias in the US Opioid
Epidemic: A Review of the History of Systemic Bias and Implications for Care" (https://www.
ncbi.nlm.nih.gov/pmc/articles/PMC6384031). Cureus. 10 (12): e3733.
doi:10.7759/cureus.3733 (https://doi.org/10.7759%2Fcureus.3733). ISSN 2168-8184 (http
s://search.worldcat.org/issn/2168-8184). PMC 6384031 (https://www.ncbi.nlm.nih.gov/pmc/a
rticles/PMC6384031). PMID 30800543 (https://pubmed.ncbi.nlm.nih.gov/30800543).
71. McLeod, A., White, I.K., and Gavin, A.R. (2003). "The Locked Ballot Box: The Impact of
State Criminal Disenfranchisement Laws on African American Voting Behavior and
Implications for Reform." Journal of Social Policy and the Law, 11, (1), 66-88.
72. Barillas, Wilber A. (2014-04-16). Collateral Damage: Drug Enforcement & Its Impact on the
Deportation of Legal Permanent Residents. Boston College Law School. OCLC 876889955
(https://search.worldcat.org/oclc/876889955).
73. "Report: The War on Marijuana in Black and White" (https://www.aclu.org/report/report-war-
marijuana-black-and-white). American Civil Liberties Union. Retrieved 2021-05-12.
74. Freeman-Wilson, Karen P.; Tuttle, Robert; Weinstein, Susan (2001). Ethical considerations
for judges and attorneys in drug court. National Drug Court Institute. OCLC 57750255 (http
s://search.worldcat.org/oclc/57750255).
75. "Derek Chauvin defense expert blames heart disease and drug use for George Floyd's
death" (https://www.washingtonpost.com/nation/2021/04/14/derek-chauvin-trial-2/).
Washington Post. ISSN 0190-8286 (https://search.worldcat.org/issn/0190-8286). Retrieved
2021-05-12.
76. "Patients with Addiction Need Treatment - Not Stigma" (https://www.asam.org/resources/pub
lications/magazine/read/article/2015/12/15/patients-with-a-substance-use-disorder-need-tre
atment---not-stigma). www.asam.org. Retrieved 2018-09-28.
77. "Employers guide to Addiction | How to get help" (https://www.addictionhelper.com/addiction/
employers/). Addiction Helper. 2014-12-08. Retrieved 2021-01-20.
78. Kim, Nathan; Welty, Susie; Reza, Tania; Sears, David; McFarland, Willi; Raymond, Henry F.
(1 June 2019). "Undiagnosed and Untreated HIV Infection Among Persons Who Inject
Drugs: Results of Three National HIV Behavioral Surveillance Surveys, San Francisco,
2009–2015". AIDS and Behavior. 23 (6): 1586–1589. doi:10.1007/s10461-018-2284-1 (http
s://doi.org/10.1007%2Fs10461-018-2284-1). PMID 30259347 (https://pubmed.ncbi.nlm.nih.
gov/30259347). S2CID 52843973 (https://api.semanticscholar.org/CorpusID:52843973).

Retrieved from "https://en.wikipedia.org/w/index.php?

title=Discrimination_against_drug_addicts&oldid=1257901056"